ISRCTN59048638已完成未知
Sulodexide in the treatment of early stages of COVID-19: A randomised controlled trial
CLINEDEM0 个研究点目标入组 243 人开始时间: 2020年6月4日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 243
研究概览
简要总结
2021 results in https://pubmed.ncbi.nlm.nih.gov/33677827/ (added 08/03/2021)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •Current participant inclusion criteria as of 09/09/2020:
- •1. Less than 3 days onset of COVID-19 suspected symptoms
- •2. Age between 40 - 80 years
- •3. Body mass index between 18 - 35 kg/m²
- •4. >50% calculated risk for severe clinical progression
- •Previous participant inclusion criteria:
- •1. Less than 3 days onset of COVID-19 suspected symptoms
- •2. Age between 40 - 80 years
- •3. Body mass index between 18 - 35 kg/m²
- •4. History of DM, hypertension, CPOD, or other chronic disease
排除标准
- •Current participant exclusion criteria as of 09/09/2020:
- •1. COVID-19 negative test.
- •2. Reluctant to take medication
- •3. Reluctant to followup
- •4. Bed confinement
- •5. Chronic use of steroids
- •6. History of deep vein thrombosis in the last 6 months
- •7. Chronic use of anticoagulation
- •8. Already in hospital care
- •9. Previous treatment for COVID-19
- •Previous participant exclusion criteria:
- •1. COVID-19 negative test.
- •2. Reluctant to take medication
- •3. Reluctant to followup
- •4. Bed confinement
- •5. Chronic use of steroids
- •6. History of deep vein thrombosis in the last 6 months
- •7. Chronic use of anticoagulation
研究者
相似试验
已完成
2 期
Suloexide in the Treatment of Early Stages of COVID-19Covid19NCT04483830Clinedem243
进行中（未招募）
1 期
Sulodexide (VESSEL®) for the prevention of a recurrent episode of deep vein thrombosis and/or pulmonary embolism in elderly patientsPrevention of recurrence after a first episode of VTEMedDRA version: 21.0Level: LLTClassification code 10043640Term: Thrombosis venousSystem Organ Class: 100000004866MedDRA version: 20.0Level: LLTClassification code 10034191Term: PESystem Organ Class: 100000004855EUCTR2019-000570-33-ITFONDAZIONE ARIANNA ANTICOAGULAZIONE1,455
终止
4 期
Endothelial Protection in Convalescent COVID-19 PatientsEndothelial DysfunctionInflammationThrombosisCOVID-19NCT05252923Pirogov Russian National Research Medical University2
招募中
3 期
Sulodexide in the Treatment of Chronic Primary Venous Disease of the Lower ExtremitiesChronic Venous DiseaseChronic Insufficiency VenousNCT05005052Value Outcomes Ltd.290
已完成
3 期
Paxlovid in the treatment of COVID-19ISRCTN12428408Wenzhou Central Hospital58